Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status
Jiyun Lee, Yoon‐La Choi, Joungho Han, Sehhoon Park, Hyun Ae Jung, Jong-Mu Su, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn
Topics & Concepts
OsimertinibMedicineT790MInternal medicineHazard ratioConfidence intervalOncologyGastroenterologyGenotypingCancerGenotypeEpidermal growth factor receptorErlotinibGeneticsGeneGefitinibBiologyLung Cancer Treatments and MutationsBrain Metastases and TreatmentLung Cancer Research Studies